Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)
NCT02529475 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2020-11-18
Summary
* This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in healthy subjects
* MR Perfusion Imaging will be assess in both cochlea as well
* Primary auditory brain pathways will be evaluated through MR diffusion imaging
Conditions
- Meniere Disease
Interventions
- DRUG
-
Gadoteric acid
Comparison with patients with Meniere's disease
Sponsors & Collaborators
-
University Hospital, Grenoble
lead OTHER
Principal Investigators
-
Arnaud ATTYE, PH · University Hospital, Grenoble
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-02-01
- Primary Completion
- 2020-09-30
- Completion
- 2020-09-30
Countries
- France
Study Locations
More Related Trials
-
Efficacy of Local Overpressure Treatment for Meniere's Disease
NCT00831688 ·Status: COMPLETED ·Phase: PHASE4
-
Feasibility of Stereotactic Image Guidance on the Lateral Skull Base
NCT03852329 ·Status: TERMINATED ·Phase: NA
-
SPI-1005 for the Treatment of Meniere's Disease
NCT04677972 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate SPI-1005 in Adults With Meniere's Disease
NCT02603081 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Latanoprost for the Treatment of Menière's Disease
NCT01973114 ·Status: UNKNOWN ·Phase: PHASE2
-
Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets
NCT04806282 ·Status: RECRUITING
-
Open Label Study of OTO-104 in Subjects With Meniere's Disease
NCT02740387 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of a Mastoid Device in Subjects With Ménière's Disease
NCT03520322 ·Status: TERMINATED ·Phase: NA
-
AM-101 in the Treatment of Acute Tinnitus 3
NCT02040194 ·Status: COMPLETED ·Phase: PHASE3
-
Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops
NCT01661777 ·Status: WITHDRAWN ·Phase: NA
-
The Influence of Covid-19 on the Audio-vestibular System
NCT04709146 ·Status: UNKNOWN ·Phase: NA
-
A 6-Month Extension Study of OTO-104 in Meniere's Disease
NCT02706730 ·Status: TERMINATED ·Phase: PHASE3
-
A 6-Month Extension Study of OTO-104 in Meniere's Disease
NCT02768662 ·Status: TERMINATED ·Phase: PHASE3
-
AM-101 in the Treatment of Post-Acute Tinnitus 2
NCT02040207 ·Status: COMPLETED ·Phase: PHASE3
-
Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease
NCT00802529 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT03664674 ·Status: COMPLETED ·Phase: PHASE3
-
Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients
NCT02420067 ·Status: RECRUITING
-
Endoscopic Transcanal Tympanoplasty With Attico-antrostomy Versus Endoscopic-assisted Canal Wall up Mastoidectomy in Management of Localized Cholesteatoma: A Randomized Clinical Trial
NCT04959539 ·Status: COMPLETED ·Phase: NA
-
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease
NCT04674735 ·Status: WITHDRAWN ·Phase: PHASE1
-
Diagnostic of Various Ototoxicity Induced by Cancer Treatment
NCT06490029 ·Status: RECRUITING
-
Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent
NCT02080312 ·Status: COMPLETED ·Phase: NA
-
Innovations in Clinical Care of CE Approved Nucleus Cochlear Implant Recipients
NCT05270876 ·Status: COMPLETED ·Phase: NA
-
OTO-104 for Meniere's Disease
NCT01084525 ·Status: COMPLETED ·Phase: PHASE1
-
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease
NCT05851508 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of SpotOn Specs™ for the Treatment of Chronic Dizziness
NCT01460121 ·Status: COMPLETED ·Phase: NA